Evaluation of CD4+ T Cells in HIV Patients Presenting with Malaria at the University of Ilorin Teaching Hospital Nigeria by Olajide O. Agbede et al.
Evaluation of CD4+ T Cells in HIV Patients Presenting with 
Malaria at the University of Ilorin Teaching Hospital Nigeria.
Olajide O. AGBEDE1, Temitope O. AJIBOYE1, Olatunji M. KOLAWOLE2a, 
Samuel A. BABATUNDE3 Louis O. ODEIGHA3, 
1 Department of Microbiology and Parasitology, College of Health Sciences,  
 P.M.B. 1515, University of Ilorin, Ilorin, Nigeria.
2
 Department of Microbiology, Faculty of Science, P.M.B. 1515, University of  
Ilorin, Ilorin, Nigeria. Email:tomak74@yahoo.com Tel: 234-8060088495  
3Department of Hematology, University of Ilorin Teaching Hospital, Ilorin,  
Nigeria.
4Department of Family Medicine, University of Ilorin Teaching Hospital, Ilorin,  
Nigeria.
These authors contributed equally to this work
 Author to whom correspondence and request for materials be addressed.
a
  Present address: Malaria I, Department of Molecular Parasitology, Bernhard    
    Nocht Institute for Tropical Medicine, Hamburg, Germany.
CD4 count is an important immunological marker of disease progression in 
HIV seropositive patients. This study was carried out to determine the effect 
of  malaria  or  fever  of  unknown  origin  on  the  population  of  CD4+  T 
lymphocytes  of  HIV  seropositive  patients  attending  the  highly  active 
antiretroviral therapy (HAART) clinic of the University of Ilorin Teaching 
Hospital, Ilorin, Nigeria. 36 Subjects were selected for this study. Ongoing 
history of fever was used as a case definition for malaria and malaria was 
confirmed from microscopic examination of  thick and thin film of  blood 
sample obtained from the patients during presentation with fever. The CD4 
count was evaluated during presentation of fever and post-fever using flow 
cytometry.  There  was  significant  decrease  in  CD4 count  of  the  patients. 
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However, upon classifying the patients into 2 groups- those that returned to 
the clinic after a week and those that returned after a month; a significant 
increase in CD4 count was noticed in the group that returned after a week, 
while a significant decrease was noticed in the group that returned after a 
month (at p value of 95%). Further classification of the patients based on 
presence  of  malaria  parasite,  and  body  temperature  resulted  in  varying 
effects on CD4 count post-fever (in the general group, 27 were positive for 
malaria parasites.  Of these 27,  there was an increase in CD4 count in 9 
(33.3%).  However in the group that returned after a week, all 6 (100%) that 
were  positive  for  malaria  parasites  showed increase  in  CD4  count.  Five 
(26.3%) of the 19 patients that had body temperature within the range of 
35.5-37.40C showed an increase in CD4 count, while 7 (41.2%) the 17 patients 
that had body temperature of 37.50C and above showed an increase in CD4 
count. The results led to the conclusion that while some components of the 
immune response to malaria could strengthen the immune system of HIV 
seropositive patients by increasing their CD4 count, other components will 
suppress their immunity by decreasing their CD4 count,  accelerating the 
progression to AIDS.    
Keywords: CD4 Count, HIV/AIDS, CD4+ T lymphocytes, Flow Cytometry, 
Malaria, Immune System    
    Human Immunodeficiency Virus (HIV) is the etiologic agent of the disease 
known as acquired immune deficiency syndrome (AIDS). It causes a progressive 
impairment of the body’s cellular immune system by destroying CD4+ T cells 
leading to increased susceptibility to various infections.  HIV/AIDS is  a major 
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public  health  problem  with  socio-economic burden  and  a  serious  threat  to 
development1.
    Nine out of 10 people living with HIV are in the developing world2. 60 to 70% 
of those are in Sub-Saharan Africa. But the disease is spreading in every region, 
with fierce epidemics threatening to tear through countries such as India, China, 
Russia and the islands of the Caribbean. As HIV spreads, it interacts with other 
infectious diseases, facilitated by the increase in numbers of immunosuppressed 
individuals and, because its own clinical course can be altered by other infections. 
     Malaria is by far the world's most important tropical parasitic disease, and kills 
more people than any other communicable disease except tuberculosis3. Malaria is 
a public health problem today in more than 90 countries, inhabited by a total of 
some 2400 million people - 40% of the world's population. Malaria is endemic in 
a total of 101 countries and territories, most of them in Africa.        
    In Africa,  the HIV pandemic has been superimposed on the longstanding 
malaria infection which is endemic, where P. falciparum malaria is consistently 
one of the major causes of infant and child mortality. The high prevalence of both 
HIV and malaria infection in Africa means that even small interactions between 
the two could have substantial effects on populations4. In more recent years, one 
of  the  key  issues  focused  on  the  relationship  between malaria  infection  and 
HIV/AIDS.
    The main question is whether malaria infection accelerates progression of 
HIV/AIDS  or  improves  the  immune  level  of  the  patient  and  is  somehow 
protective.  Many interesting  studies  have  been  conducted  on  the  relationship 
between these two potentially fatal diseases, but a general consensus is yet to be 
reached on the effects, if  any, of malaria parasitaemia on the underlying HIV 
infection in patients.
    Studies conducted by5  seemed to suggest that malarial infection leads to an 
increase in the HIV viral load, thereby potentially hastening the progression of 
HIV to full blown AIDS. The findings in that study indicated that this increased 
viral load was reversed by effective malaria treatment. Others have reported an 
increase  in  the  CD4+ counts  of  HIV patients  during  the  course  of  malarial 
infection, thereby improving the prognosis of the HIV infection6. The latter group 
has hinted at the possibility of repeatedly inducing malaria in HIV patients so as 
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to boost their immunity and prevent the progression to AIDS. This is referred to 
as malariotherapy, a treatment reminiscent of what was done for neurosyphilis in 
the 1920s by the Austrian doctor, Wagner Jauregg6.
    Plasmodium falciparum infection is endemic in most tropical countries and will 
definitely infect HIV patients living in this region at one time or the other during 
the course of their infection. Hence, it is important to determine the effect malaria 
parasites will have on the quality of life of HIV patients, especially since other 
intercurrent infections in HIV are being effectively controlled.
      
Methods
Study Area.  The study was carried out  at  the  University  of  Ilorin  Teaching 
Hospital (UITH), a tertiary and referral hospital located in Ilorin, the Kwara state 
capital. It is a 486-bed hospital  7 involved in teaching, research and training of 
medical students and resident doctors. It is an affiliate of University of Ilorin 
through, the College of Health Sciences.
Subjects.  Thirty six (36) HIV seropositive patients presenting with fever were 
recruited in this study following approval by the Ethics and research committee of 
the Hospital and due consent of the patients.  Based on the sample size of this 
study, the subjects had to be grouped into two broad temperature categories, for 
proper  statistical  analysis.  The  temperature  ranges  were;  35.50C-  37.40C and 
37.50C-39.80C.
        
Blood Collection. Aseptic procedures were adopted in the collection of the blood 
samples. 5ml of venous blood was obtained using sterile needle and syringe and 
dispensed into EDTA bottles8.
CD4+ T cell Count. CD4 counts of the patients were evaluated during fever and 
post fever using a Partec Flow Cytometer. 20µl of whole blood was placed in a 
rohren tube, and 20µl of CD4+ T cell monoclonal antibodies was added. The tube 
was then incubated in the dark for 15 minutes at room temperature after which 
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800µl of buffer was added. The tube was then placed in the Partec flow cytometer. 
The value of CD4+ T cells per ml in the sample of blood was then obtained from 
a programmed computer connected to the instrument8. 
Preparation of Thin and Thick Blood Film. The preparation of both thick and 
thin  blood films for  confirmation  of  parasitaemia  were  carried  out  using  the 
methods described by9. 
 Microscopic Examination. A drop of immersion oil was placed on the stained 
thin film and another  drop on thick film. They were examined systematically 
using x 100 objectives (oil immersion objective).Identification was done by the 
method described by9. 
Statistical Methods.  The variation in CD4 count during and after episodes of 
malaria and fever are given as percentage proportion. Variations were categorized 
as increase and decrease. Differences between the categories were analyzed by T-
test of equality in proportion. 
    In order to determine if any significant variation in CD4 count is due to the 
action of malaria parasite or fever, patients were examined for malaria parasite. 
The  observations  were  analyzed  for  significance  using  T-Test  of  equality  of 
proportion, a two-way analysis of variance (ANOVA) and Chi square.   
Results. There was a decrease in the mean difference of the CD4 count of the 
patients. Of the total 36 samples evaluated, a decrease in the value of CD4+ T 
lymphocytes was observed in 24 (66.7%) samples, while an increase was noticed 
in the remaining 12 (33.3%) samples. However, when the subjects were divided 
into 2 groups based on the time of their return to the clinic (10 returned after a 
week while the remaining 26 returned after a month), the result varied. There was 
an increase in the CD4 count of the patients 1 week post fever presentation when 
compared with the count obtained at fever presentation. Of the 10 samples 
evaluated, an increase was noticed in 8 (80%), while a decrease in the value of 
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CD4+ T lymphocytes was observed in the 2 (20%) remaining samples. The CD4 
counts of 26 patients were evaluated during fever, and 1 month post fever 
presentation. Those that returned after a month had a decrease in the mean values 
of the CD4 count. Of these 26 patients, 22 (84.6%) showed a decrease in CD4 
count, while the remaining 4 (15.4%) showed an increase in CD4 count (Table 
1). 
   There was also variation in CD4 count of the subjects in relation to presence of 
malaria parasite. Of the 36 patients involved in this study, 27 were positive for 
malaria parasites, while the remaining 9 were negative. Of the 27 samples that 
were  positive  for  malaria  parasite,  there  was an increase  in  CD4 count  in  9 
(33.3%), while there was a decrease in CD4 count in 18 (66.7%).  Also, of the 9 
samples that were negative for malaria parasite, 3 (33.3%) showed an increase in 
CD4 count, while 6 (66.7%) showed a decrease in CD4 count. Statistically, the 
difference in the blood malaria status, in patients that showed increase in CD4 
count was significant (Table 2). 
 
Table 1: Values of CD4+ T cells in HIV seropositive patients during 
fever and post fever presentation.
 Health Status              Samples          Increase in                  Decrease in  
                                                              CD 4 Count                 CD4 Count
  General                         36                          12 (33.3%)                    24 (66.7%)
 1 Week post-                  10                            8 (80%)                        2 (20%)
   Fever               
   
  1 month post- fever        26                         22 (84.6%)                     4 (15.6%)
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Table  2: Influence  of  blood  malaria  status  on variation  in  CD4 
Counts in HIV patients after presentation with fever 
Malaria Parasite           Increase in CD4 count      Decrease in CD4 count
                                           (Mean Difference)             (Mean Difference) 
Positive                                     9 (168.1)                            18 (120.2)   
Negative                                   3 (20.3)                                6 (109.7)
       When the variation in CD4 count in relation to malaria parasite in patients 
that reported back to the clinic after a week was checked, 6 of the 10 of them were 
positive for malaria parasite, while the remaining 4 were negative (Table 3). All 
6 (100%) patients that were positive for malaria parasite showed an increase in 
CD4 count. Of the 4 that were negative for malaria parasite, 2 (50%) showed an 
increase  in  CD4  count,  while  the  remaining  2  (50%)  showed  a  decrease. 
Statistically, the difference in the blood malaria status, in patients that showed 
increase in CD4 counts was significant (p< 0.05). 
Table  3: Influence  of  blood  malaria  status  on  variation  in  CD4 
counts 1 week after presentation with fever.  
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Malaria Parasite         Increase in CD4 counts       Decrease in CD4 counts 
                                         (Mean Difference)              (Mean Difference)
Positive                              6 (171)                                    0    
Negative                             2 (27)                                      2 (195.5)
    Body temperature during fever did not have a significant influence on variation 
in CD4 count in the overall group (Table 4). It must be noted that for some of the 
subjects, their body temperature was below 37.50C, which is the body temperature 
indicative of fever. Nineteen patients had body temperature within the range of 
35.5-37.40C, while 17 had body temperature of 37.50C and above.  Of the 19 
patients that had body temperature within the range of 35.5-37.40C, 5 (26.3%) 
showed an increase in CD4 count, while 14 (73.7%) showed a decrease. Of the 17 
patients that had body temperature of 37.50C and above, 7 (41.2%) showed an 
increase in CD4 count while 10 (58.8%) showed a decrease. The difference was 
not statistically significant (p> 0.05). 
Table 4: Influence of body temperature on variations in CD4 counts 
during fever, and after presentation with fever in HIV sero-positive 
patients.  
Temperature            Increase in CD4 count            Decrease in CD4 count
        (0C)                       (Mean Difference)                   (Mean Difference)
35.5-37.4                       5 (109)                                      14 (126.4)   
37.5-39.80C                    7 (153.4)                                  10 (99.0) 
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    Three patients had body temperature within the range of 35.5-37.40C, while 7 
had body temperature of 37.50C and above. Of these total of 10 patients, 8 had 
increase in CD4+ T cells, while the remaining 2 had a decrease. Three out of the 8 
that had an increase in CD count had body temperature within the range of 35.5-
37.40C.  The  remaining  5  had  body  temperature  of  37.50C  and  above.  The 
difference was statistically significant (p<0.05) (Table 5). 16 patients had body 
temperature within the range of 35.5-37.40C, while 10 had body temperature of 
37.50C and above. Of the 16 patients that had body temperature within the range 
of 35.5-37.40C, 2 showed an increase in CD4 count, while 14 showed a decrease. 
Of the 10 patients that had body temperature of 37.50C and above, 2 showed an 
increase in CD4 count while 8 showed a decrease. The mean differences was 
statistically significant (p< 0.05)(Table 6). 
 
Table 5: Influence of body temperature on variations in CD4 counts 
during  fever,  and  one  week  after  presentation  with  fever  in  HIV 
sero-positive patients.  
Temperature            Increase in CD4 count          Decrease in CD4 count
        (0C)                       (Mean Difference)                 (Mean Difference)
35.5-37.4                     3 (94.1)                                       0   
37.5-39.80C                 5 (160.2)                                     2 (195.5) 
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Table 6: Influence of body temperature on variations in CD4 counts 
during  fever,  and  one  month  post  fever  presentation  in  HIV 
seropositive patients.
 
Temperature            Increase in CD4 count          Decrease in CD4 count
        (0C)                      (Mean Difference)                 (Mean Difference)
35.5-37.4                   2 (109)                                         14 (126.3)   
37.5-39.80C                2 (136.5)                                      8 (82) 
Discussion
    This work has attempted to provide answers to some controversial issues of the 
consequence of malaria parasite infection in HIV seropositive individuals. It is not 
known whether malaria accelerates the progression of HIV to full-blown AIDS or 
ameliorates HIV infection by fever-inducing mechanism. To achieve this,  the 
CD4+ T cell  counts of  the blood samples obtained from the 36 patients  that 
participated in this study were evaluated during, and after episodes of malaria and 
fever  of non-malarial  origin.  Ongoing history of fever was used as a  clinical 
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definition of malaria and malaria was confirmed from microscopic examination of 
thin and thick film. 
    There were variations in the CD4 cell count, during and after fever, in all 36 
patients, and the pattern of variation differed based on the different groups of the 
patients (Table 1).  While some patients had increased CD4 counts post-fever, 
others showed a decrease. The variations in CD4 counts observed in this work are 
concomitant to similar studies that had been carried out previously confirming the 
fact  that  malaria  does  have  an  effect  on  the  underlying  infection  in  HIV 
seropositive  patients.  6,  10,  11all  noted  changes  in  the  CD4  counts  of  HIV 
seropositive patients after episodes of malarial disease. 
    Generally, a decrease in CD4 count was observed in this study (Table 1). This 
seems to support the claims of10,  12.  Hviid reported that malaria-specific T cell 
responses and even unrelated T cell  responses are  down regulated during the 
course of malaria infection12. The study carried out by10 focused on the viral load 
of HIV patients that participated. They reported an increase in the viral load of the 
patients following episodes of malaria. Increase in viral load, if sufficient enough, 
will  cause  a  decrease  in  CD4 count.  This  could  also  be  responsible  for  the 
decrease in CD4 count noticed in thisstudy.         
    Some of the patients that participated in this study returned after a week while 
the rest returned after a month. A significant increase in CD4 count was noticed in 
the group that  returned after  a  week. This is  concomitant with6,  in which an 
increase  in  CD4  count  in  HIV  patients  infected  with  malaria  parasites  was 
reported. The presence of malaria parasite increases production of cytokines by 
the immune system in an effort to ward off the invading organism. The cytokines 
produced  can  also  activate  CD4+ T  lymphocytes,  strengthening  the  immune 
system6. This could account for the increase in CD4 count noticed in this group, 
and this observation seems to lend credence to Heimlich’s argument that malaria 
can  be  used  in  boosting  the  immunity  of  HIV patients,  a  procedure  termed 
“malariotherapy”, improving their prognosis. 
   However,  in  the  group that  returned  after  a  month,  there  was significant 
decrease  in  CD4  count  post-fever,  indicating  possible  acceleration  of  HIV 
infection towards AIDS. This result seems to confirm the observation reported 
by5.  It  was observed that an increase in HIV load could eventually lead to a 
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decrease in CD4 count. This could have been as a result of the action of pro - 
inflammatory  cytokine  such  as  TNF- .  P.  falciparum has  been  shown  to 
stimulate HIV-1 replication through the production of cytokines such as TNF-  
and interleukin-613. 
   The results observed above (Table 1) suggest that the various components of 
the immune response mounted to challenge the presence of malaria parasites in 
the body will have varying effects on the T lymphocyte population of the patients 
that participated in this study. Cytokines have been reported to exert  multiple 
actions  that  affect  the  activity  of  multiple  cell  types14.  This  is  referred  to  as 
cytokine pleiotropy. TNF-  and IL-10, which have been reported to be produced 
during  malarial  disease15,  have varying effects  on different  cell  types,  and  at 
different times16. Differences in the quality of variation observed in these 2 groups 
suggest  that  the  pleiotropic  nature  of  some of  the  cytokines  involved  in  the 
immune response of the body to malaria may have had varying effects on the 
population of CD4+ T cells. 
   Some patients that participated in this study had low level of parasitaemia as 
observed from the microscopic examination of their blood film (Table 4). TNF-
 has been reported to be involved in the cell mediated immune response against 
malaria,  preventing parasitaemia by stimulating neutrophils  and monocytes to 
phagocytosize parasites17,  18. This could account for the level of parasitaemia in 
patients in this group.  There was significant decrease in CD4 count of these 
patients. 19  in a study into the effect of malaria on the viral load in HIV patients 
noticed a significantly higher HIV-proviral  load in patients with malaria than 
those without, and this remained higher for at least 4 weeks after treatment. This 
increase in IHV load could lead to a decrease in CD4 count and may account for 
the decrease in CD4 count of patients in this group. This would suggest that 
malaria causes faster progression of HIV disease. 
   Another bone of contention in the overall debate as to the effect of malaria on 
HIV is whether any noticeable effect is due to the presence of malaria parasites or 
the fever induced during malarial disease. Comparison in CD4 count variation 
was made in subjects that were positive for malaria parasites and those that were 
negative (Tables 2 and 3). There was significant increase in CD4 count in those 
that had malaria parasites.  20  in a  Study carried out in a children's hospital in 
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Kinshasa,  Congo,  followed  112  children  with  AIDS,  41  of  whom also  had 
malaria. They reported that none of the 41 children with malaria and AIDS died, 
all recovered from their  malaria. However, of the remaining 71 children with 
AIDS without malaria, 25 (35%) died. 
   A similar result was observed in patients that returned after a week (Table 3). 
All of the patients in this group who were positive for malaria parasite showed an 
increase  in  CD4  counts.  The  continuous  release  of  malarial  pyrogenes  that 
stimulate CD4+ T cells was lingering in those with malaria parasites such that 
there was still increase in CD4 count after a week as opposed to those who were 
malaria-parasite negative, who showed significant decrease in CD4 count within a 
week.   The results  observed in  Tables  2 and  3 seem to suggest  that malaria 
parasites play a key role  in the stimulation of the immune system enough to 
produce  increase  in  the  population  of  CD4+  T  lymphocytes  which  can  be 
beneficial to HIV patients. 
   This study also attempted to investigate the effect of the quality of fever, as 
indicated by body temperature, on the CD4 cell count during malaria and fever of 
other origins. Based on the sample size examined in this study, the subjects had to 
be grouped into two broad temperature categories, for proper statistical analysis. 
The temperature ranges were; 35.50C- 37.40C and 37.50C-39.80C  (Table 4).  It 
must be noted that for some of the subjects, their body temperature was below 
37.50C, which is the body temperature indicative of fever. It has been established 
that time affects the production of cytokines21.  This is significant because the 
paroxysm associated  with  malaria  is  often  experienced  around evening  time, 
while  the  temperature  was  taken  in  the  morning  (during  clinic).  This  could 
account for the reason why some of the patients had body temperature less than 
that indicative of fever. 
   In the overall group, there was no significant variation in CD4 count of the 
subjects based on their body temperature during malarial disease (Table 4). This 
seems to suggest that the effect of malaria fever on the CD4 count of HIV positive 
patient does not depend on the quality of fever induced. If this is so, it reflects the 
results observed in some of the patients that underwent malariotherapy in the 
treatment of neurosyphilis. According to6, some patients were cured even when 
the malaria did not produce high fevers. 
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    However, when the effect of quality of fever on the CD4 count of the HIV 
patients that participated in this study were analyzed based on the time of their 
return to the clinic post fever, significant variations were noticed. In the group 
that returned after a week (Table 5), temperature had a significant effect as more 
of those that had body temperature equal to or greater than 37.50C had an increase 
in CD4 count, while for the group that returned after a month, a significantly 
higher number of them showed a decrease in CD4 count (Table 6). This seems to 
suggest that quality of fever may have a bearing on the effect of malaria fever on 
the CD4 count of HIV patients depending on the time interval between the peak of 
malarial disease and the remission of fever. This may be as a result of the diverse 
nature and effects exerted by the cytokines involved in the immune response to 
the presence of pathogens. The process of fever induction involves the activation 
of CD4+ T cells by pyrogens22. The activation of T-helper cells could have been 
strong enough to activate a high population of T cells. This activation will lead to 
an  increase  in  CD4  count.  The  cytokines  that  normally  induce  fever  were 
probably still activating CD4+ T cells in the group that returned after a week, as 
opposed to those that returned after a month, in which the effects of the fever-
inducing cytokines have probably worn off. This could explain the significant 
increase in CD4 count observed in patients with body temperature indicative of 
fever in the patients that returned after a week, and significant decrease in those 
that returned after a month. 
   In conclusion, episodes of malaria fever in HIV patients elicit varying immune 
responses with attendant effect on the patients. It is therefore important to further 
investigate the various components of the immune system to malaria and the parts 
they play in the response to the presence of malaria parasites. Also, due to the fact 
that a significantly higher number of the patients eventually showed a decrease in 
CD4 count post-fever, it is imperative to continue the on-going efforts to protect 
HIV patients, as well as everybody from malaria attacks. 
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